Opioid-induced constipation can be a frustrating and debilitating side effect of pain management. Fortunately, medical professionals now have access to naloxegol, a medication that specifically targets this issue. In this comprehensive guide, we'll unpack everything you need to know about naloxegol, including its pros and cons, potential side effects, and cost. By the end of this article, you'll have a thorough understanding of how naloxegol works and whether it's the right treatment option for your patients with opioid-induced constipation. So let's dive in!
Naloxegol, also known as Movantik, is a medication used to treat opioid-induced constipation. While it has been proven effective in relieving constipation symptoms caused by opioids, like any other medication, it has its pros and cons.
One of the main advantages of Naloxegol is that it works by blocking the opioid receptors in the gut without affecting pain relief. This means that patients can continue taking their prescribed opioids while also managing their constipation symptoms.
Another advantage is that Naloxegol has a lower risk of abuse than other medications for constipation relief because it does not produce a high or euphoric effect.
On the downside, some common side effects of Naloxegol include abdominal pain, diarrhea, nausea, vomiting and headaches. In rare cases, patients may experience severe allergic reactions which require immediate medical attention.
Another disadvantage is that Naloxegol should be used with caution in patients with liver problems or those taking medications metabolized by CYP3A4 enzymes because it may increase drug levels in the blood leading to potential adverse drug interactions.
Naloxegol is an effective medication for treating opioid-induced constipation, but like any other drug, it comes with potential side effects. While most patients tolerate naloxegol well, some may experience adverse reactions.
One of the most common side effects of Naloxegol is nausea. Patients may feel queasy and uncomfortable after taking the medication. Other gastrointestinal symptoms like diarrhea, vomiting and abdominal pain have also been reported in some cases.
In rare instances, naloxegol can lead to severe allergic reactions such as hives or swelling of the face. In case this happens to a patient, immediate medical attention should be sought.
Some people may also experience headaches while using naloxegol. Dizziness and fatigue are other possible side effects that could affect daily activities.
Naloxegol is a promising medication for managing opioid-induced constipation in patients who are not responding well to other laxatives. It has been shown to be effective and generally safe with few side effects.
As medical professionals, it is important to understand the pros and cons of using naloxegol as part of our treatment strategies. We must monitor our patients closely for any potential side effects and educate them on how to properly use the medication.
Naloxegol offers another option for managing opioid-induced constipation and can greatly improve the quality of life for those suffering from this condition.
1.
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer
2.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
3.
Is Laughter Good for Blood Glucose Control?
4.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
5.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
1.
All You Need to Know About Mesna: The Ultimate Guide
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Uncovering the Reality of Colon Cancer: A Look at Real Images
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation